Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
In univariate analysis, all 29 adiposity and metabolic measures assessed were associated with ' g ' at P < 0.05.
-
This analysis provides a comprehensive overview of the AI-related research conducted in the field of health care, which helps researchers, policy makers, and practitioners better understand the development of health care-related AI research and possible practice implications.
-
While aggregation of neuroimaging datasets from multiple sites and scanners can yield increased statistical power, it also presents challenges due to systematic scanner effects.
-
Cerebrovascular risk factors are associated with Parkinson disease, an effect comparable to their association with Alzheimer disease.
-
Sensory impairments are associated with greater risk of dementia in Chinese older adults.
-
It is unclear how or whether oral health and cognitive status are related.
-
An increased incidence of mild cognitive impairment was observed in community-dwelling elderly adults who had nonpsychotic psychiatric symptoms at baseline.
-
Thirty full-text articles met the eligibility criteria.
-
Lower RBC DHA levels are associated with smaller brain volumes and a "vascular" pattern of cognitive impairment even in persons free of clinical dementia.
-
Key neuropathological changes associated with late-onset dementia are not fully understood.
-
60/100
Neuropsychiatric symptoms are common features of MCI.
-
Increasing frailty is associated with incident AD and the rate of cognitive decline in older persons.
-
Using the best available data, our survey of a limited number of disorders shows that the burden of neurologic illness affects many millions of people in the United States.
-
Depression symptoms before the onset of AD are associated with the development of AD, even in families where first depression symptoms occurred more than 25 years before the onset of AD.
-
After multivariable adjustment, longer sleep duration was associated with lower Aβ42/40, poor sleep quality with higher NfL, daytime sleepiness with both lower Aβ42/40 and higher NfL, and insomnia symptoms with higher SPARE-AD.
-
Our analysis yielded three major a marked acceleration in research activity since 2020, a convergence of clinical needs with technological advancements, and the inherently interdisciplinary nature of this field.
-
Alzheimer's disease (AD) is a global healthcare challenge lacking a simple and affordable detection method.
-
59/100
DL-ADprob was independently prognostic in both ADNI-MCI (P < .001) and HABS-CU (P = .048) sets.
-
59/100
Baseline pRBD was associated with faster decline in global cognition and all cognitive domains, including verbal episodic memory, visuospatial ability, executive function, language, and processing speed.
-
Numerous longitudinal studies suggest a strong association between cardiovascular risk factors and cognitive impairment.
-
The study included 1 789 participants (1 206 with AD, 111 with DLB, 49 with VaD, and 423 with NC).
-
Our results demonstrate that 1-h daily treatment with Cognito's Evoked Gamma Therapy System (CogTx-001) was safe and well-tolerated and demonstrated potential clinical benefits in mild to moderate AD.
-
Both total CogEvo and MMSE scores significantly decreased with age.
-
59/100
Previous studies have demonstrated resilience to AD-related neuropathology in a form of cognitive reserve (CR).
-
Physical activity moderated the association between MTA and plasma Aβ42/40 level and increased dementia risk.